NFE2L2 and renal fibrosis: Low-intensity pulsed ultrasound, a non-invasive therapeutic modality delivered in pulse wave mode, has recently received increased attention for its potential role in modulating the Nrf2/Keap1/HO-1 pathway, thereby effectively suppressing renal fibrosis [122,138].